The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 28, 2015
Filed:
Mar. 24, 2014
Applicant:
Edison Pharmaceuticals, Inc., Mountain View, CA (US);
Inventors:
Andrew W. Hinman, San Francisco, CA (US);
Kieron E. Wesson, Burlingame, CA (US);
Orion D. Jankowski, Burlingame, CA (US);
William D. Shrader, Belmont, CA (US);
Edgar P. Lee, Mountain View, CA (US);
Assignee:
Edison Pharmaceuticals, Inc., Mountain View, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 275/22 (2006.01); C07D 295/195 (2006.01); C07C 45/00 (2006.01); C07C 45/30 (2006.01); C07C 205/34 (2006.01); C07C 233/31 (2006.01); C07C 233/61 (2006.01); C07C 233/76 (2006.01); C07C 235/34 (2006.01); C07C 235/40 (2006.01); C07C 235/78 (2006.01); C07C 255/57 (2006.01); C07C 255/60 (2006.01); C07C 311/03 (2006.01); C07C 311/16 (2006.01); C07C 311/29 (2006.01); C07D 209/08 (2006.01); C07D 211/46 (2006.01); C07D 213/56 (2006.01); C07D 213/75 (2006.01); C07D 213/82 (2006.01); C07D 215/08 (2006.01); C07D 217/06 (2006.01); C07D 295/215 (2006.01); C07D 311/74 (2006.01); C07D 317/66 (2006.01); C07D 319/18 (2006.01); C07D 339/04 (2006.01); C07C 275/30 (2006.01); C07C 311/17 (2006.01);
U.S. Cl.
CPC ...
C07D 295/195 (2013.01); C07C 45/00 (2013.01); C07C 45/30 (2013.01); C07C 205/34 (2013.01); C07C 233/31 (2013.01); C07C 233/61 (2013.01); C07C 233/76 (2013.01); C07C 235/34 (2013.01); C07C 235/40 (2013.01); C07C 235/78 (2013.01); C07C 255/57 (2013.01); C07C 255/60 (2013.01); C07C 275/22 (2013.01); C07C 275/30 (2013.01); C07C 311/03 (2013.01); C07C 311/16 (2013.01); C07C 311/17 (2013.01); C07C 311/29 (2013.01); C07D 209/08 (2013.01); C07D 211/46 (2013.01); C07D 213/56 (2013.01); C07D 213/75 (2013.01); C07D 213/82 (2013.01); C07D 215/08 (2013.01); C07D 217/06 (2013.01); C07D 295/215 (2013.01); C07D 311/74 (2013.01); C07D 317/66 (2013.01); C07D 319/18 (2013.01); C07D 339/04 (2013.01); C07C 2101/02 (2013.01); C07C 2101/14 (2013.01); C07C 2101/16 (2013.01);
Abstract
Methods of treating or suppressing oxidative stress diseases including mitochondrial diseases, impaired energy processing disorders, neurodegenerative diseases and diseases of aging are disclosed, as well as compounds useful in the methods of the invention, such as 2-substituted-p-quinone derivatives as disclosed herein.